Advanced Parkinson's disease: Clinical characteristics and treatment. Part II
Introduction: Many patients who have had Parkinson's disease (PD) for several years will present severe motor fluctuations and dyskinesias which require more aggressive therapies. The different approaches which are now available include deep brain stimulation of the subthalamic nucleus or media...
Main Authors: | J. Kulisevsky, M.R. Luquin, J.M. Arbelo, J.A. Burguera, F. Carrillo, A. Castro, J. Chacón, P.J. García-Ruiz, E. Lezcano, P. Mir, J.C. Martinez-Castrillo, I. Martínez-Torres, V. Puente, Á. Sesar, F. Valldeoriola-Serra, R. Yañez |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier España
2013-11-01
|
Series: | Neurología (English Edition) |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2173580813001132 |
Similar Items
-
Enfermedad de Parkinson avanzada. Características clínicas y tratamiento (parte I)
by: J. Kulisevsky, et al.
Published: (2013-10-01) -
Spanish expert consensus on the use of safinamide in Parkinson's disease
by: F. Valldeoriola, et al.
Published: (2021-11-01) -
Uso de la infusión intestinal continua de levodopa-carbidopa en pacientes con enfermedad de Parkinson avanzada en España. Subanálisis por comunidades autónomas
by: D. Santos-García, et al.
Published: (2021-03-01) -
Continuous intestinal infusion of levodopa–carbidopa in patients with advanced Parkinson's disease in Spain: Subanalysis by autonomous community
by: D. Santos-García, et al.
Published: (2021-03-01) -
Erratum: Pagonabarraga, J.; et al. A Spanish Consensus on the Use of Safinamide for Parkinson’s Disease in Clinical Practice. <i>Brain Sci.</i> 2020, <i>10</i>, 176
by: Javier Pagonabarraga, et al.
Published: (2020-05-01)